Viracta Logo Brand
    • Welcome
    • News & Events
      News Releases Events and Webcasts
    • Corporate Governance
      Governance Documents Board of Directors Board Committees
    • SEC Filings
    • Stock Information
      Interactive Chart Historical Stock Price Analyst Coverage
    • FAQs
    • Investor Alerts
      Investor Alerts RSS

SEC Filings

0001061027NASDAQ: VIRX
YearTrailing 12-MonthsCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2012Calendar Year 2010Calendar Year 2009
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
S-4/APre-effective amendment to an S-4 filingJan 13, 2021Open Pre-effective amendment to an S-4 filing in HTML.Open Pre-effective amendment to an S-4 filing in DOC file.Open Pre-effective amendment to an S-4 filing in PDF file.Open Pre-effective amendment to an S-4 filing in XLS file.Open Pre-effective amendment to an S-4 filing in XBLR Viewer.Open Pre-effective amendment to an S-4 filing in XBLR file.
Viracta Logo Brand

© 2023 Viracta Therapeutics, Inc.

Explore

  • Company
    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
  • Pipeline
  • Investors
  • Careers
  • Contact

Contact

2533 S. Coast Hwy 101
Suite 210
Cardiff, CA 92007

Direct: 858-400-8470
info@viracta.com

Follow

Legal

Terms of Use
Privacy Policy